Kanser Ara\u015ft\u0131rmalar\u0131 Enstit\u00fcs\u00fc ve Imperial College London taraf\u0131ndan y\u00fcr\u00fct\u00fclen geni\u015f kapsaml\u0131 \u00e7al\u0131\u015fma, t\u0131p d\u00fcnyas\u0131nda alarm zillerinin \u00e7almas\u0131na neden oldu. Ara\u015ft\u0131rma sonu\u00e7lar\u0131na g\u00f6re, \u00f6zellikle ba\u011f\u0131rsak ve yumurtal\u0131k kanseri ba\u015fta olmak \u00fczere toplam 11 kanser t\u00fcr\u00fc, gen\u00e7 yeti\u015fkinler aras\u0131nda ge\u00e7mi\u015fe oranla \u00e7ok daha yayg\u0131n g\u00f6r\u00fclmeye ba\u015fland\u0131.<\/p>\n\n\n\n
Bilim insanlar\u0131, bu art\u0131\u015f\u0131n ard\u0131ndaki nedeni tam olarak saptayamasa da obezite oranlar\u0131ndaki art\u0131\u015f\u0131n bir fakt\u00f6r olabilece\u011fini belirtiyor. Ancak \u015fa\u015f\u0131rt\u0131c\u0131 olan; sigara kullan\u0131m\u0131, alkol t\u00fcketimi ve k\u0131rm\u0131z\u0131 et t\u00fcketimi gibi kanseri tetikledi\u011fi bilinen al\u0131\u015fkanl\u0131klar\u0131n bu ya\u015f grubunda sabit kalmas\u0131na veya iyile\u015fmesine ra\u011fmen vakalar\u0131n artmas\u0131. Bu durum, art\u0131\u015f\u0131n arkas\u0131nda hen\u00fcz tam ke\u015ffedilememi\u015f \u00e7evresel veya biyolojik nedenler olabilece\u011fini g\u00f6steriyor.<\/p>\n\n\n\n
D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (WHO) verilerine g\u00f6re ba\u011f\u0131rsak kanseri (kolorektal kanser), d\u00fcnya genelinde en yayg\u0131n \u00fc\u00e7\u00fcnc\u00fc kanser t\u00fcr\u00fc ve kansere ba\u011fl\u0131 \u00f6l\u00fcmlerin en b\u00fcy\u00fck ikinci nedeni konumunda. 2020 y\u0131l\u0131nda 1,9 milyondan fazla yeni vaka g\u00f6r\u00fcl\u00fcrken, 930 bin ki\u015fi bu hastal\u0131k nedeniyle hayat\u0131n\u0131 kaybetti.<\/p>\n\n\n\n
Bir\u00e7ok vakada erken evrede belirti vermeyen ba\u011f\u0131rsak kanserinde uzmanlar, bireysel kontrollerin hayati \u00f6nem ta\u015f\u0131d\u0131\u011f\u0131n\u0131 vurguluyor. \u0130\u015fte dikkat edilmesi gereken ba\u011f\u0131rsak kanseri belirtileri:<\/p>\n\n\n\n
D\u0131\u015fk\u0131da de\u011fi\u015fiklik: \u0130shal veya kab\u0131zl\u0131k gibi rutin de\u011fi\u015fimlerin 3 haftadan uzun s\u00fcrmesi.<\/p>\n\n\n\n
Kanama: D\u0131\u015fk\u0131da parlak k\u0131rm\u0131z\u0131, koyu k\u0131rm\u0131z\u0131 veya siyah g\u00f6r\u00fcn\u00fcml\u00fc kan.<\/p>\n\n\n\n
A\u011fr\u0131 ve \u015ei\u015fkinlik: Kar\u0131nda yumru hissi, ge\u00e7meyen \u015fi\u015fkinlik veya \u015fiddetli a\u011fr\u0131.<\/p>\n\n\n\n
Genel Durum: A\u00e7\u0131klanamayan kilo kayb\u0131 ve s\u00fcrekli yorgunluk hissi.<\/p>\n\n\n\n
T\u00fcrkiye\u2019de Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131, 50-70 ya\u015f aras\u0131ndaki vatanda\u015flara her iki y\u0131lda bir \u00fccretsiz d\u0131\u015fk\u0131da gizli kan taramas\u0131 (KETEM, ASM ve TSM\u2019lerde) ve 10 y\u0131lda bir kolonoskopi \u00f6neriyor. Ancak ailesinde kanser \u00f6yk\u00fcs\u00fc olanlar i\u00e7in bu s\u0131n\u0131r 40 ya\u015f\u0131na \u00e7ekiliyor. Uzmanlar, \u0130ngiltere\u2019de ilk kez denenen ki\u015fiye \u00f6zel kanser a\u015f\u0131s\u0131 gibi yeni teknolojilerin umut verici oldu\u011funu belirtirken, mevcut en iyi korunma y\u00f6nteminin sa\u011fl\u0131kl\u0131 ya\u015fam ve d\u00fczenli takip oldu\u011funu hat\u0131rlat\u0131yor.<\/p>\n\n\n\n